Panbela Therapeutics Средняя величина рекомендации
Что обозначает Средняя величина рекомендации в Panbela Therapeutics?
Средняя величина рекомендации Panbela Therapeutics Inc. является 2.50
Какое определение для Средняя величина рекомендации?
Средняя величина рекомендации является средним значением рейтингов аналитиков от 1,0 (активно покупать) до 5,0 (активно продавать).
Mean of recommendations is an average of ratings from different analysts but it should still be used with other research and investment metrics in order to make investment decisions. It is important to understand a firm's entire scale when assimilating ratings. Additionally, analyst recommendations on stocks owned by firms employing them may be seen as potentially biased.
Financial analysts are often employed by mutual and pension funds, hedge funds, securities firms, banks, investment banks, insurance companies, and other businesses, helping these companies or their clients make investment decisions. Financial analysts employed in commercial lending perform "balance sheet analysis," examining the audited financial statements and corollary data in order to assess lending risks. In a stock brokerage house or in an investment bank, they read company financial statements and analyze commodity prices, sales, costs, expenses, and tax rates in order to determine a company's value and project future earnings. In any of these various institutions, the analyst often meets with company officials to gain a better insight into a company's prospects and to determine the company's managerial effectiveness.
Usually, financial analysts study an entire industry, assessing current trends in business practices, products, and industry competition. They must keep abreast of new regulations or policies that may affect the industry, as well as monitor the economy to determine its effect on earnings.
Средняя величина рекомендации компаний в Health Care сектор на NASDAQ по сравнению с Panbela Therapeutics
Что делает Panbela Therapeutics?
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.
Компании с средняя величина рекомендации похож на Panbela Therapeutics
- Revvity имеет Средняя величина рекомендации из 2.47
- Cardinal Health имеет Средняя величина рекомендации из 2.47
- Cintas имеет Средняя величина рекомендации из 2.47
- Textron имеет Средняя величина рекомендации из 2.47
- Ralph Lauren Corp имеет Средняя величина рекомендации из 2.48
- NOV Inc имеет Средняя величина рекомендации из 2.48
- Panbela Therapeutics имеет Средняя величина рекомендации из 2.50
- Landbridge имеет Средняя величина рекомендации из 2.52
- Urban Outfitters имеет Средняя величина рекомендации из 2.52
- Wells Fargo & Co имеет Средняя величина рекомендации из 2.52
- United Airlines Inc имеет Средняя величина рекомендации из 2.52
- Cognizant Technology Solutions имеет Средняя величина рекомендации из 2.52
- Grupo Aeroportuario Del Pacifico SAB de CV имеет Средняя величина рекомендации из 2.53